Literature DB >> 11948880

Design and evaluation of pilicides: potential novel antibacterial agents directed against uropathogenic Escherichia coli.

A Svensson1, A Larsson, H Emtenäs, M Hedenström, T Fex, S J Hultgren, J S Pinkner, F Almqvist, J Kihlberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11948880     DOI： 10.1002/1439-7633(20011203)2:12<915::AID-CBIC915>3.0.CO;2-M

Source DB:  PubMed          Journal:  Chembiochem        ISSN： 1439-4227            Impact factor:   3.164


× No keyword cloud information.
  40 in total

Review 1.  Stress wars: the direct role of host and bacterial molecular chaperones in bacterial infection.

Authors:  Brian Henderson; Elaine Allan; Anthony R M Coates
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 2.  The biology and future prospects of antivirulence therapies.

Authors:  Lynette Cegelski; Garland R Marshall; Gary R Eldridge; Scott J Hultgren
Journal:  Nat Rev Microbiol       Date:  2008-01       Impact factor: 60.633

Review 3.  Anti-virulence strategies to combat bacteria-mediated disease.

Authors:  David A Rasko; Vanessa Sperandio
Journal:  Nat Rev Drug Discov       Date:  2010-01-18       Impact factor: 84.694

Review 4.  Chemical inhibitors of the type three secretion system: disarming bacterial pathogens.

Authors:  Miles C Duncan; Roger G Linington; Victoria Auerbuch
Journal:  Antimicrob Agents Chemother       Date:  2012-07-30       Impact factor: 5.191

Review 5.  Pili Assembled by the Chaperone/Usher Pathway in Escherichia coli and Salmonella.

Authors:  Glenn T Werneburg; David G Thanassi
Journal:  EcoSal Plus       Date:  2018-03

Review 6.  A review on anti-adhesion therapies of bacterial diseases.

Authors:  Arezoo Asadi; Shabnam Razavi; Malihe Talebi; Mehrdad Gholami
Journal:  Infection       Date:  2018-10-01       Impact factor: 3.553

Review 7.  Novel strategies to combat bacterial virulence.

Authors:  Susan V Lynch; Jeanine P Wiener-Kronish
Journal:  Curr Opin Crit Care       Date:  2008-10       Impact factor: 3.687

Review 8.  Development of Protein-Protein Interaction Inhibitors for the Treatment of Infectious Diseases.

Authors:  Andrew F Voter; James L Keck
Journal:  Adv Protein Chem Struct Biol       Date:  2017-08-24       Impact factor: 3.507

Review 9.  Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.

Authors:  Valerie P O'Brien; Thomas J Hannan; Hailyn V Nielsen; Scott J Hultgren
Journal:  Microbiol Spectr       Date:  2016-02

10.  Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM.

Authors:  Frédéric A Carvalho; Nicolas Barnich; Adeline Sivignon; Claude Darcha; Carlos H F Chan; Clifford P Stanners; Arlette Darfeuille-Michaud
Journal:  J Exp Med       Date:  2009-09-08       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.